Skip to content
value.today
Total raised
$29 M
4 rounds on record
Latest round
$9 M
Nov 2024
First round on record
Nov 2018
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Dermasensor, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Nov 2024$9 MNo. 4$2 to $10 million

Dermasensor, Inc.: Raise no. 4, Nov 2024

Investors in this round

41 investors had bought by the notice of Dec 5, 2024: 41 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$9 M of $17 M offered; $8 M still to sell
Smallest investment taken
$4,200
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$213,543
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Cody Simmons · Executive Officer, Director
  • Christopher Dewey · Director
  • David Matlin · Director
  • Maurice Ferre · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Ceros Financial Services (CRD 37869) · Rockville, MarylandSold in all US states

Signed by Cody Simmons, Chief Executive Officer. Source: SEC Form D, newest notice filed Dec 5, 2024. Read the notice at the SEC.

equitySEC
Dec 2021$9 MNo. 3$2 to $10 million

Dermasensor, Inc.: Raise no. 3, Dec 2021

Investors in this round

168 investors had bought by the notice of Dec 21, 2021: 168 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$9 M of $10 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$786,500
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Cody Simmons · Executive Officer

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Ceros Financial Services Inc. (CRD 37869) · Rockville, MarylandSold in all US states
  • Newbridge Securities Corp (CRD 104065) · Boca Raton, FloridaSold in all US states

Signed by Cody Simmons, Chief Executive Officer. Source: SEC Form D, newest notice filed Dec 21, 2021. Read the notice at the SEC.

equitySEC
Feb 2020$6 MNo. 2$2 to $10 million

Dermasensor, Inc.: Raise no. 2, Feb 2020

Investors in this round

97 investors had bought by the notice of Mar 17, 2020: 97 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $10 M offered; $4 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$305,366
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Cody Simmons · Executive Officer · Chief Executive Officer
  • Cristiane Benvenuto · Executive Officer · Chief Medical Officer
  • Christopher Dewey · Director
  • David Matlin · Director
  • Ivan Delevic · Director
  • Maurice Ferre · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • NEWBRIDGE SECURITIES CORP. (CRD 104065) · Boca Raton, FloridaSold in AR, CA, CO, CT, DC, FL, GA, IA, IL, MA, MD, MI, MN, MO, NC, NJ, NY, OH, OK, PA, RI, SC, TX, VA, WA, WI
  • CEROS FINANCIAL SERVICES, INC. (CRD 37869) · Rockville, MarylandSold in all US states

Signed by Cody Simmons, Ceo. Source: SEC Form D, newest notice filed Mar 17, 2020. Read the notice at the SEC.

equitySEC
Nov 2018$6 MNo. 1$2 to $10 million

Dermasensor, Inc.: Raise no. 1, Nov 2018

Investors in this round

23 investors had bought by the notice of Dec 19, 2018: 23 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M (amount offered: indefinite)
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Cody Simmons · Executive Officer · Chief Executive Officer

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Cody Simmons, Chief Executive Officer. Source: SEC Form D, newest notice filed Dec 19, 2018. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Dermasensor, Inc. reported revenue of $418,596 for its most recent fiscal year (filed Sep 2026), up from $107,717 the year before.

    SEC Form C/A · Sep 2026

  • The direct cost of what it sold was $99,407, so 76% of its revenue was left after those costs.

    SEC Form C/A · Sep 2026

  • Net loss for the same year: $6.70 million.

    SEC Form C/A · Sep 2026

  • Dermasensor, Inc. chose not to state its revenue in its newest notice of a funding round (Dec 2024).

    SEC Form D · Dec 2024

  • The industry group it chose in its notices: Other.

    SEC Form D · Dec 2024

In its own words

How the company describes itself to search engines on its website, word for word.

“An AI-powered device helping physicians detect skin cancer at the point of care, with 96% sensitivity across all three common skin cancers. Request a demo.”

Source: The company's website · as of Nov 15, 2026

Products and services#

No products or services on record: its website does not describe any in structured form (a page that declares itself a product or service), and Wikidata lists none.

Investors#

No investor of Dermasensor, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 168 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Dermasensor, Inc.
NameRoleNamed in
Cody SimmonsExecutive officerDec 2024
Cristiane BenvenutoChief Medical OfficerMar 2020
Christopher DeweyDirectorDec 2024
Cody SimmonsDirectorDec 2024
David MatlinDirectorDec 2024
Maurice FerreDirectorDec 2024
Ivan DelevicDirectorMar 2020